Burke W Whitman
CIK 1188191 · President and CEO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HMA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 250
ATLANTA, GA 30327
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OHI | Director | 47,931 | $45.64 | $2.19M | $333.3K | 26 | 2026-06-09 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | $427.0K | 28 | 2026-04-27 |
| HEALTH MANAGEMENT ASSOCIATES, INC (HMA) Delisted | President and CEO | 832,664 | $10.54 | $8.78M | $2.45M | 5 | 2008-08-08 |
Recent Filings · Page 5 of 6
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-05 | OHI | Buy (P) | +500 | $15.9K | EDGAR |
| 2020-08-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Buy (P) | +1,500 | $21.8K | EDGAR |
| 2020-07-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Buy (P) | +1,500 | $22.8K | EDGAR |
| 2020-07-02 | OHI | Buy (P) | +500 | $14.9K | EDGAR |
| 2020-06-17 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +16,667 | $0 | EDGAR |
| 2020-06-15 | OHI | Grant (A) | +4,597 | $150.0K | EDGAR |
| 2020-06-08 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +5,855 | $0 | EDGAR |
| 2020-06-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Buy (P) | +2,000 | $25.3K | EDGAR |
| 2020-06-01 | OHI | Buy (P) | +800 | $25.4K | EDGAR |
| 2019-08-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Buy (P) | +4,945 | $49.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.